NL189207C - Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis. - Google Patents

Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.

Info

Publication number
NL189207C
NL189207C NLAANVRAGE8603017,A NL8603017A NL189207C NL 189207 C NL189207 C NL 189207C NL 8603017 A NL8603017 A NL 8603017A NL 189207 C NL189207 C NL 189207C
Authority
NL
Netherlands
Prior art keywords
intermediates
preparing
preparation
vaccine against
japanese encephalitis
Prior art date
Application number
NLAANVRAGE8603017,A
Other languages
English (en)
Dutch (nl)
Other versions
NL189207B (nl
NL8603017A (nl
Original Assignee
Univ Osaka Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Osaka Res Found filed Critical Univ Osaka Res Found
Publication of NL8603017A publication Critical patent/NL8603017A/nl
Publication of NL189207B publication Critical patent/NL189207B/xx
Application granted granted Critical
Publication of NL189207C publication Critical patent/NL189207C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NLAANVRAGE8603017,A 1986-06-05 1986-11-27 Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis. NL189207C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13120886 1986-06-05
JP61131208A JPH0768267B2 (ja) 1986-06-05 1986-06-05 フラビウイルス抗原

Publications (3)

Publication Number Publication Date
NL8603017A NL8603017A (nl) 1988-01-04
NL189207B NL189207B (nl) 1992-09-01
NL189207C true NL189207C (nl) 1993-02-01

Family

ID=15052566

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8603017,A NL189207C (nl) 1986-06-05 1986-11-27 Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.

Country Status (9)

Country Link
US (1) US4810492A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH0768267B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE905815A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1270780A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3641040A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2599626B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2191201B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1198289B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL189207C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH084508B2 (ja) * 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
JP2511494B2 (ja) * 1988-05-12 1996-06-26 善治 松浦 日本脳炎ウイルス表面抗原蛋白質の製造法
US6184024B1 (en) 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
US6676936B1 (en) 1988-07-14 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services. Chimeric and/or growth-restricted flaviviruses
FR2654113A1 (fr) * 1989-11-09 1991-05-10 Pasteur Institut Procede de diagnostic de virus appartenant a la famille des flaviviridae.
SE470074B (sv) * 1990-08-16 1993-11-01 Replico Medical Ab Förfarande för diagnos av picorna- och/eller flavivirusinfektion, peptider, diagnostiska antigener och vaccinkomposition med dessa peptider
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
CA2224724C (en) * 1995-05-24 2007-12-04 Hawaii Biotechnology Group, Inc. Subunit vaccine against flavivirus infection
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
US7417136B1 (en) 1998-06-04 2008-08-26 The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
DK2278012T3 (en) 2000-02-16 2015-12-07 Us Government Immunogenic dengue 2 virus chimeras
AU2003263853A1 (en) * 2002-08-16 2004-03-03 Board Of Regents The University Of Texas System Compositions and methods related to flavivirus envelope protein domain iii antigens
CA2503303A1 (en) * 2002-11-08 2004-05-27 The Administrators Of The Tulane Educational Fund Flavivirus fusion inhibitors
CA2973863C (en) 2009-07-31 2022-05-17 Ge Healthcare Bio-Sciences Corp. High yield yellow fever virus strain with increased propagation in cells
WO2014150939A2 (en) 2013-03-15 2014-09-25 Takeda Vaccines, Inc Compositions and methods for dengue virus chimeric constructs in vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1981-08-04 1984-08-04 Univ California
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
WO1988003032A1 (en) * 1986-10-27 1988-05-05 Fournier Maurielle J Diagnosis of and vaccine for japanese encephalitis virus and related viruses

Also Published As

Publication number Publication date
NL189207B (nl) 1992-09-01
BE905815A (nl) 1987-03-16
FR2599626A1 (fr) 1987-12-11
DE3641040A1 (de) 1987-12-10
IT1198289B (it) 1988-12-21
CA1270780A (en) 1990-06-26
GB8628072D0 (en) 1986-12-31
US4810492A (en) 1989-03-07
JPS62286930A (ja) 1987-12-12
NL8603017A (nl) 1988-01-04
FR2599626B1 (fr) 1992-02-28
DE3641040C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-10-26
JPH0768267B2 (ja) 1995-07-26
GB2191201B (en) 1991-01-23
IT8622505A0 (it) 1986-11-28
GB2191201A (en) 1987-12-09

Similar Documents

Publication Publication Date Title
NL189207C (nl) Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.
FI891896L (fi) Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa
NL171063B (nl) Werkwijze ter bereiding van muramyldipeptidederivaten en van een farmaceutisch preparaat.
DE3886363D1 (de) NANBV-Diagnostika und Vakzine.
DE3785404D1 (de) Impfstoffe.
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
DE2963977D1 (en) Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
FI871313A7 (fi) Menetelmä lääkeadsorbaattien valmistamiseksi.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
IL82235A (en) Immunogen complexes, their preparation and vaccines comprising them
NL7804345A (nl) Imidazoazinen en imidazodiazinen, werkwijze ter berei- ding daarvan en farmaceutische preparaten.
DE2862086D1 (en) Antigenic, immunogenic herpes virus subunit and process for preparing it
BE853810A (fr) Procede de preparation d'un vaccin contre le virus, de la rhinopneumonie equine et vaccin ainsi obtenu
NL7707555A (nl) Ceriumsulfadiazinen en werkwijze voor de be- reiding daarvan, werkwijze voor de bereiding van preparaten en preparaten gevormd met de werkwijze.
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
DK196687A (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
DE3776920D1 (de) Waessriges praeparat und verfahren zu dessen herstellung.
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
EP0290565A4 (en) VACCINE CONTAINING TICK ANTIGENS.
FI875309A7 (fi) Konjugaattirokote.
FI906051L (fi) Malariavaccin.
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
NO900442L (no) Vaksineblanding.
NL7710518A (nl) Werkwijze ter bereiding van een therapeutisch preparaat, alsmede de aldus bereide, gevormde therapeutische preparaten.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20020601